甘化科工(000576.SZ):5月起停止開展食糖類業務
格隆匯5月11日丨甘化科工(000576.SZ)公佈,公司於2022年5月11日召開的第十屆董事會第十四次會議審議通過了《關於停止開展食糖類業務的議案》,根據公司發展戰略及經營狀況,公司將於2022年5月起停止開展食糖類業務。停止開展食糖類業務的原因:1、食糖類業務盈利能力不強;2、為使主營業務與發展戰略更加匹配。
目前公司主營業務有彈藥零部件、電源及相關產品等軍工業務和食糖貿易。2021年度公司實現營業收入5.40億元,其中軍工板塊營業收入3.17億元,佔比58.7%,毛利率為67.06%;食糖類營業收入2.16億元,佔比39.96%,毛利率為0.60%。食糖類業務雖佔公司整體營業收入比重較大,但貢獻的經營效益很小,投入的資金使用效率不高。預計停止開展食糖類業務不會對公司正常經營運作帶來影響,有利於公司集中資源,聚焦發展軍工產業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.